Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

537.50INR
10:22am GMT
Change (% chg)

Rs0.35 (+0.07%)
Prev Close
Rs537.15
Open
Rs537.00
Day's High
Rs543.95
Day's Low
Rs525.85
Volume
708,471
Avg. Vol
952,715
52-wk High
Rs972.95
52-wk Low
Rs525.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun 23,630.00 11.534
FY 2017 Mar '17 24,571.80 7.489
Dec 25,350.10 16.250
Sep 22,241.10 7.774
Jun 19,693.80 7.720
FY 2016 Mar '16 23,066.80 6.519
Dec 17,783.00 6.030
Sep 19,093.60 7.010
Jun 16,477.40 6.768
FY 2015 Mar '15 17,758.10 0.391
Dec 17,013.10 4.231
Sep 16,807.10 6.085
Jun 14,869.40 6.810
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 20 29,410.10 34,047.00 26,355.00 --
Quarter Ending Jun-18 1 22,429.70 22,429.70 22,429.70 --
Year Ending Mar-17 32 95,801.20 103,747.00 87,815.80 --
Year Ending Mar-18 29 94,630.60 108,391.00 90,858.90 104,445.00
Year Ending Mar-19 29 105,004.00 125,734.00 97,777.00 117,233.00
Earnings (per share)
Quarter Ending Mar-17 8 20.04 28.90 13.88 --
Quarter Ending Jun-18 2 9.67 9.84 9.50 --
Year Ending Mar-17 34 51.63 68.00 32.70 --
Year Ending Mar-18 30 37.62 47.70 28.02 52.83
Year Ending Mar-19 30 43.06 56.70 35.63 56.96
LT Growth Rate (%) 1 10.62 10.62 10.62 24.21
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 14.21 31.14 32.93
P/E High - Last 5 Yrs. 44.88 40.91 45.62
P/E Low - Last 5 Yrs. 20.22 23.80 24.34
Beta 0.27 0.90 0.88
Price to Sales (TTM) 1.80 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) 11.58 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 0.33 1.56 1.50
Dividend Yield - 5 Year Avg 0.29 1.57 1.52
Dividend 5 Year Growth Rate 0.00 4.33 5.17
Payout Ratio(TTM) 5.59 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 19.99 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 21.15 4.66 5.38
Sales - 5 Yr. Growth Rate 17.97 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 49.41 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 57.35 -- --
EPS - 5 Yr. Growth Rate 18.22 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 21.27 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) 6.69 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.69 55.14 54.83
Gross Margin - 5 Yr. Avg. 67.81 52.29 52.40
EBITD Margin (TTM) 23.33 -- --
EBITD - 5 Yr. Avg 20.85 18.46 15.24
Operating Margin (TTM) 19.61 14.50 7.76
Operating Margin - 5 Yr. Avg. 15.96 14.42 10.75
Pre-Tax Margin (TTM) 16.60 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. 13.24 14.74 11.17
Net Profit Margin (TTM) 12.70 11.22 4.88
Net Profit Margin - 5 Yr. Avg. 10.15 11.08 7.47
Effective Tax Rate (TTM) 23.51 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. 23.32 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,387,447 953,213,828 864,680,848
Net Income/Employee (TTM) 937,855 112,151,383 101,718,394
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) -- 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.42 11.00
Return on Assets - 5 Yr. Avg. 8.04 13.00 12.43
Return on Investment (TTM) -- 14.86 14.46
Return on Investment - 5 Yr. Avg. 12.35 17.00 16.28
Return on Equity (TTM) -- 16.28 16.05
Return on Equity - 5 Yr. Avg. 23.02 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 20.08 15.22 17.97
EPS (TTM) % 48.44 25.24 18.22
Dividend % 0.00 0.00 0.00
Note: Units in Millions of US Dollars

Performance for Glenmark Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.55 5.13 99 25
13 Week -7.94 -9.25 99 37
26 Week -29.02 -33.73 72 30
52 Week -33.69 -41.42 65 12
YTD -31.07 -42.31 67 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 22.70%
# of Holders: 119
Total Shares Held: 64,056,257
3 Mo. Net Change: 5,089,383
# New Positions: 4
# Closed Positions: 13
# Increased Positions: 39
# Reduced Positions: 29
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.